A three-dimensional experimental system has been developed to study the response to drugs in low-grade glioma, a tumor of the …
Pharma Newswire™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC
Category:
Medical Comms
-
-
Medical Comms
A pioneering drug capable of reversing cognitive decline in Alzheimer’s disease in animal models
by Newsroomby NewsroomA team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering …
-
Medical Comms
Plastic bottles transformed into Parkinson’s drug using bacteria
by Newsroomby NewsroomA drug to treat Parkinson’s disease can be made from waste plastic bottles using a pioneering method, a study shows. …
-
Medical Comms
Pfizer’s Phase 2 study of trispecific antibody positive in moderate to severe atopic dermatitis
by Newsroomby NewsroomPfizer Inc. (NYSE: PFE) announced positive topline results from a Phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate …
-
A new experimental treatment for children with a hard-to-treat form of epilepsy is safe and can reduce seizures dramatically, helping …
-
Medical Comms
Abbott and Real Madrid launch nationwide effort to build the next ‘Abbott Dream Team’
by Newsroomby NewsroomAbbott (NYSE: ABT) announced today the launch of the second year of the ‘Abbott Dream Team,’ encouraging young soccer players …
-
Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful compounds. In a new …
-
Researchers from Tokyo Metropolitan University have created a new molecule which carries DNA into biological cells, to treat or vaccinate …
-
Medical Comms
Accelerating next generation medicine with new drug delivery platform
by Newsroomby NewsroomScientists have developed an adaptable materials platform that can safely and efficiently deliver a wide range of genetic medicines, a …
-
Patients who use semaglutide for weight loss, like Ozempic, are more likely to continue the medication if they perceive it …